co
Corporate
Observer
Homepage
Data
Great Britain
Company
ENTERPRISE THERAPEUTICS LTD

ENTERPRISE THERAPEUTICS LTD

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source

    • Overview

    Company NameENTERPRISE THERAPEUTICS LTD
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 09022750
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of ENTERPRISE THERAPEUTICS LTD?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is ENTERPRISE THERAPEUTICS LTD located?

    Registered Office Address
    Sussex Innovation Centre Science Park Square
    Falmer
    BN1 9SB Brighton
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for ENTERPRISE THERAPEUTICS LTD?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnJun 30, 2026
    Next Accounts Due OnMar 31, 2027
    Last Accounts
    Last Accounts Made Up ToDec 31, 2025

    What is the status of the latest confirmation statement for ENTERPRISE THERAPEUTICS LTD?

    Last Confirmation Statement Made Up ToMay 02, 2027
    Next Confirmation Statement DueMay 16, 2027
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMay 02, 2026
    OverdueNo

    What are the latest filings for ENTERPRISE THERAPEUTICS LTD?

    Filings
    DateDescriptionDocumentType

    Previous accounting period shortened from Dec 31, 2026 to Jun 30, 2026

    		1 pagesAA01

    Confirmation statement made on May 02, 2026 with no updates

    		3 pagesCS01

    Full accounts made up to Dec 31, 2025

    		27 pagesAA

    Previous accounting period shortened from Jun 30, 2026 to Dec 31, 2025

    		1 pagesAA01

    Full accounts made up to Jun 30, 2025

    		27 pagesAA

    Previous accounting period shortened from Dec 31, 2025 to Jun 30, 2025

    		1 pagesAA01

    Confirmation statement made on May 02, 2025 with no updates

    		3 pagesCS01

    Full accounts made up to Dec 31, 2024

    		27 pagesAA

    Confirmation statement made on May 02, 2024 with no updates

    		3 pagesCS01

    Full accounts made up to Dec 31, 2023

    		25 pagesAA

    Full accounts made up to Dec 31, 2022

    		25 pagesAA

    Confirmation statement made on May 02, 2023 with no updates

    		3 pagesCS01

    Second filing of Confirmation Statement dated May 02, 2022

    		4 pagesRP04CS01

    Second filing of Confirmation Statement dated May 02, 2021

    		8 pagesRP04CS01

    Confirmation statement made on May 02, 2022 with no updates

    		4 pagesCS01
    Annotations
    DateAnnotation
    May 27, 2023Clarification A second filed CS01 (statement of capital and shareholders information) was registered on 27/05/2023

    Full accounts made up to Dec 31, 2021

    		30 pagesAA

    Full accounts made up to Dec 31, 2020

    		31 pagesAA

    Director's details changed for John Ford on Aug 19, 2020

    		2 pagesCH01

    Resolutions

    Resolutions
    		4 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of varying share rights or name

    		RES12
    incorporation

    Resolution of adoption of Articles of Association

    		RES01

    Termination of appointment of Johnathan Craig Richardson as a director on May 20, 2021

    		1 pagesTM01

    Termination of appointment of Amit Munshi as a director on May 20, 2021

    		1 pagesTM01

    Change of share class name or designation

    		2 pagesSH08

    Memorandum and Articles of Association

    		11 pagesMA

    Particulars of variation of rights attached to shares

    		2 pagesSH10

    Termination of appointment of Bart Dzikowski as a director on May 20, 2021

    		1 pagesTM01
    View All Filings

    Who are the officers of ENTERPRISE THERAPEUTICS LTD?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    BOYD, Philip James, Dr
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		Secretary
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		222208620001
    FORD, John William, Dr
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		Director
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		United KingdomBritish180692170003
    DANAHAY, Henry, Dr
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		Director
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		United KingdomBritish187336720001
    DZIKOWSKI, Bart
    Novartis Campus (Forum 1-1.32
    Lichtstrasse 35
    Basel
    Novartis Venture Fund
    4056
    Switzerland
    		Director
    Novartis Campus (Forum 1-1.32
    Lichtstrasse 35
    Basel
    Novartis Venture Fund
    4056
    Switzerland
    		SwitzerlandCanadian265813100001
    FINAN, Peter Michael, Dr
    George Street
    EH2 4JY Edinburgh
    137a
    United Kingdom
    		Director
    George Street
    EH2 4JY Edinburgh
    137a
    United Kingdom
    		EnglandBritish189408570001
    GOSLING, Martin, Dr
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		Director
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		United KingdomBritish187368130001
    MAYWEG, Alexander Volker, Dr
    4051 Basel
    Aeschenvorstadt 36
    Switzerland
    		Director
    4051 Basel
    Aeschenvorstadt 36
    Switzerland
    		SwitzerlandGerman275125800001
    MCCARTHY, Clive, Dr
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		Director
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		United KingdomBritish187368140001
    MORRIS, David
    4.610
    5300 Chiron Way
    94608 Emeryville
    Novartis Venture Fund
    California
    United States
    		Director
    4.610
    5300 Chiron Way
    94608 Emeryville
    Novartis Venture Fund
    California
    United States
    		United StatesAmerican245183120001
    MULDER, Geert-Jan
    1411DC Naarden
    Gooimeer 2-35
    Netherlands
    		Director
    1411DC Naarden
    Gooimeer 2-35
    Netherlands
    		NetherlandsDutch245151560001
    MUNSHI, Amit
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		Director
    Science Park Square
    Falmer
    BN1 9SB Brighton
    Sussex Innovation Centre
    England
    		United StatesAmerican,Swiss275125880001
    RICHARDSON, Johnathan Craig, Dr
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		Director
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		United KingdomBritish262695000001
    ROPER, Elizabeth
    George Street
    EH2 4JY Edinburgh
    137a
    United Kingdom
    		Director
    George Street
    EH2 4JY Edinburgh
    137a
    United Kingdom
    		United KingdomIrish183745010001
    SONI, Bobby G., Dr
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		Director
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		United KingdomAmerican242032160001
    STOREY, John Mervyn David, Professor
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		Director
    Morris Drive
    RH14 9SF Billingshurst
    14
    West Sussex
    United Kingdom
    		ScotlandBritish72740360002
    WOODMAN, Robbie, Dr
    Air Street
    W1B 5AD London
    7
    United Kingdom
    		Director
    Air Street
    W1B 5AD London
    7
    United Kingdom
    		EnglandBritish182259660002
    IP2IPO SERVICES LIMITED
    25 Wallbrook
    EC4N 8AF London
    The Wallbrook Building
    United Kingdom
    		Director
    25 Wallbrook
    EC4N 8AF London
    The Wallbrook Building
    United Kingdom
    Identification TypeEuropean Economic Area
    Registration Number05325867
    		122951520001
    View Detailed Information on Officers and People with Significant Control

    Who are the persons with significant control of ENTERPRISE THERAPEUTICS LTD?

    Persons with significant controls
    NameNotified OnAddressCeased
    BN1 9SB Falmer, Brighton
    Sussex Innovation Centre Science Park Square
    United Kingdom
    		Oct 05, 2020
    BN1 9SB Falmer, Brighton
    Sussex Innovation Centre Science Park Square
    United Kingdom
    		No
    Legal FormCorporate
    Country RegisteredEngland And Wales
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies House
    Registration Number12868901
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		Feb 07, 2020
    25 Walbrook
    EC4N 8AF London
    The Walbrook Building
    United Kingdom
    		Yes
    Legal FormCorporate
    Country RegisteredUnited Kingdom
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies House
    Registration Number10360684
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Princes Gate
    Exhibition Road
    SW7 2PG London
    52
    United Kingdom
    		Apr 06, 2016
    Princes Gate
    Exhibition Road
    SW7 2PG London
    52
    United Kingdom
    		Yes
    Legal FormCorporate
    Country RegisteredEngland And Wales
    Legal AuthorityUnited Kingdom (England And Wales)
    Place RegisteredCompanies House
    Registration NumberOc333709
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    George Street
    EH2 4JY Edinburgh
    137a
    Scotland
    Scotland
    		Apr 06, 2016
    George Street
    EH2 4JY Edinburgh
    137a
    Scotland
    Scotland
    		Yes
    Legal FormCorporate
    Country RegisteredScotland
    Legal AuthorityScotland
    Place RegisteredCompanies House
    Registration NumberSc437985
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    View Detailed Information on Persons with Significant Control

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0